26
Jun
For many Americans, the rising tide of prescription drug prices seems like a relentless force, threatening to swamp family budgets and access to health care. While pharmaceutical companies often assume public responsibility, the web of influences on drug costs is much more intricate. Today we shine our spotlight on a critical, but typically hidden, player in this system: pharmacy benefit managers, or PBMs. Rebecca Robbins, a leading investigative journalist specializing in pharmaceuticals for the New York Times, will take us on a deep dive into the world of PBMs. We will explore their role as intermediaries between drug manufacturers, insurers,…